{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:46:57Z","timestamp":1771267617388,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:00:00Z","timestamp":1586563200000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejca.2019.03.009","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T06:35:26Z","timestamp":1554964526000},"page":"55-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A case of merkel leptomeningeal evolution after complete remission upon anti\u2013PD-1 treatment"],"prefix":"10.1016","volume":"113","author":[{"given":"Marion","family":"Godeau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Pages-Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maella","family":"Severino-Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Guinard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Larrieu-Ciron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solene M.","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Riffaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Sibaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Boulinguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2019.03.009_bib1","doi-asserted-by":"crossref","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.ejca.2019.03.009_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fneur.2017.00409","article-title":"Merkel cell carcinoma with distant metastasis to the Clivus causing symptoms Mimicking Tolosa-Hunt Syndrome: a case report and literature review","volume":"8","author":"Ho","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.ejca.2019.03.009_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2016.02.002","article-title":"A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma","volume":"52","author":"Walsh","year":"2016","journal-title":"Hum Pathol"},{"issue":"26","key":"10.1016\/j.ejca.2019.03.009_bib4","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 blockade with Pembrolizumab in advanced merkel-cell carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ejca.2019.03.009_bib5","article-title":"Abstract CT074: non-comparative, open-label, multiple cohort, phase 1\/2 study to evaluate nivolumab (NIVO) in patients with virus-associated tumors (CheckMate 358): efficacy and safety in Merkel cell carcinoma (MCC)","volume":"77","author":"Topalian","year":"2017","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2019.03.009_bib6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.03.009_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1752-1947-5-35","article-title":"Extensive central nervous system involvement in Merkel cell carcinoma: a case report and review of the literature","volume":"5","author":"Abul-Kasim","year":"2011","journal-title":"J Med Case Rep"},{"issue":"11","key":"10.1016\/j.ejca.2019.03.009_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"issue":"10","key":"10.1016\/j.ejca.2019.03.009_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1338237","article-title":"Immune evasion mechanisms and immune checkpoint inhibition in advanced merkel cell carcinoma","volume":"6","author":"Schadendorf","year":"2017","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.ejca.2019.03.009_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/imt.14.111","article-title":"Rationale for combining immunotherapy with chemotherapy","volume":"7","author":"Dalgleish","year":"2015","journal-title":"Immunotherapy"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919302059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919302059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:24:24Z","timestamp":1760732664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919302059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":10,"alternative-id":["S0959804919302059"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.03.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of merkel leptomeningeal evolution after complete remission upon anti\u2013PD-1 treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}